HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
Zhi Yang, Xiaodi Jiang, Deming Li, Xiaofeng Jiang
Abstract
METTL3-mediated MYC mRNA m6A modification. The study offers a comprehensive understanding of HBXIP as a potential therapeutic target to limit GC progression.
Topics & Concepts
Messenger RNACancer researchCancerMedicineChemistryInternal medicineGeneBiochemistryRNA modifications and cancerCancer-related gene regulationHVDC Systems and Fault Protection